SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-014743
Filing Date
2024-04-16
Accepted
2024-04-16 08:00:41
Documents
15
Period of Report
2024-04-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39750
2 ex99-1.htm EX-99.1 100425
3 ex99-1_001.jpg GRAPHIC 2717
  Complete submission text file 0001493152-24-014743.txt   331960

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE vbiv-20240416.xsd EX-101.SCH 3024
5 XBRL LABEL FILE vbiv-20240416_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE vbiv-20240416_pre.xml EX-101.PRE 22365
19 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3494
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 24846139
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)